AbbVie closes $200M Nimble Therapeutics acquisition
AbbVie closes $200M Nimble Therapeutics acquisition
STARTS NOW! Rebel Edge 🏴☠️1pm line up: U.S. crude oil prices are dropping due to weak demand from China and expected higher U.S. production after the election. WTI is notably lower, part of a wider commodity slump. Stocks $TSLA $COIN $ABBV $HOOD Sports Detroit's kicker makes 58… https://t.co/mZXNAn84q8 https://t.co/HBCDrov0gz
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more
AbbVie to buy Aliada Therapeutics for $1.4B in cash
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
374.36BUSD
Lihat miliarder mana yang memiliki investasi ini
Jenis
Common Stock
Menukarkan
NYSE
Kode mata uang
USD
Nama Mata Uang
US Dollar
Nama negara
USA
ISO Negara
US
ADALAH
US00287Y1091
CUSIP
00287Y109
Sektor
Healthcare
Industri
Drug Manufacturers - General
Akhir Tahun Anggaran
December
tanggal IPO
-
Diperbarui Pada
-
Rasio PE
88.51
Rasio PEG
0.44
Nilai buku
1.88
Pembagian Dividen
6.29
Hasil Dividen
3.09%
Bagi Hasil
2.39
Target Harga Wall Street
211.05
Estimasi EPS Tahun Ini
12.28
Estimasi EPS Tahun Depan
13.88
Perkiraan EPS Kuartal Saat Ini
2.258
Estimasi EPS Kuartal Berikutnya
2.5852
Kuartal Terbaru
-
Pendapatan TTM
56,334,000,128
TTM Laba Kotor
39,608,999,936
EBITDA
26,208,000,000
Margin Keuntungan
7.59%
Pengembalian Aset TTM
8.26%
Pengembalian Ekuitas TTM
62.29%
Pendapatan Per Saham TTM
31.845
Pertumbuhan Pendapatan Kuartalan YOY
5.60%
Eps TTM yang diencerkan
2.39
Pertumbuhan Pendapatan Kuartalan YOY
-12.30%
tertinggal PE
88.51
Maju PE
17
Harga Jual TTM
6.6294
Buku Harga MRQ
112.319
Pendapatan Nilai Perusahaan
7
EBITDA Nilai Perusahaan
29
77.20
1.85%812.00
1.51%43.19
0.77%77.04
0.67%344.01
0.65%109.00
0.00%368.50
-1.60%153.56
-0.58%162.22
-0.48%94.64
-0.07%Daftar pantauan pilihan di mana ABBV ditampilkan.